China is
one of the fastest growing global economies with a fifth population in the
world, and is one of the largest healthcare markets around the world. Along
with sustained economic and population growth as well as an ageing population,
Chinese healthcare market has maintained annually average growth rate above 16
% since 1990s. Among them, medical devices represented dynamical growth since
2000s.
By 2014,
total value of medical devices on Chinese healthcare market has reached 255.6
billion RMB (about 40.25 billion US dollars). Medical devices have been widely
used in the process of disease prevention, diagnosis, therapy, care and
rehabilitation.
On the
Chinese medical device market, imported overseas medical devices made by
overseas and multinational medical device manufacturers account for about a
half, in which the high-tech and high-valued medical devices, such as magnetic
resonance imaging (MRI) equipments, computed tomography (CT) equipments are
almost monopolized by GE, Siemens, Philips and other overseas and multinational
companies.
For
more information kindly visit: http://www.radiantinsights.com/research/latest-guide-to-chinese-medical-device-gmp-regulations
It is
estimated that Chinese medical device market will be likely to be more than 340
billion RMB (about 53.15 billion US dollars) by 2015, and will surpass Japan to
become the second largest medical device market behind the United States.
Undoubtedly, China has an indispensable medical device market for overseas and
multinational medical device companies. It’s definitely a field worth playing
on.
However,
since October 2014, Chinese regulatory authorities have significantly changed
the regulations on medical devices. China Food and Drug Administration (CFDA)
issued the latest Chinese Good Manufacturing Practice (GMP) Regulations for
Medical Devices on December 29, 2014, which has come into force as March 1,
2015.
On July
10, 2015, China Food and Drug Administration (CFDA) further issued the latest
Implementation Regulations of Good Manufacturing Practice (GMP) for Sterile
Medical Devices, Implementation Regulations of Good Manufacturing Practice
(GMP) for Implantable Medical Devices as the appendices of the latest Chinese
Good Manufacturing Practice (GMP) Regulations for Medical Devices respectively.
They have
come into force as October 1, 2015. Furthermore, on September 25, 2015, China
Food and Drug Administration (CFDA) issued the latest On-site Inspection
Guideline of Good Manufacturing Practice (GMP) for Medical Devices, On-site
Inspection Guideline for Sterile Medical Device GMP Implementation Regulations,
and On-site Inspection Guideline for Implantable Medical Device GMP
Implementation Regulations. Everything changed.
About Us
Radiant Insights is a platform for companies looking to meet their
market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
No comments:
Post a Comment